NO963143L - Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne - Google Patents

Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne

Info

Publication number
NO963143L
NO963143L NO963143A NO963143A NO963143L NO 963143 L NO963143 L NO 963143L NO 963143 A NO963143 A NO 963143A NO 963143 A NO963143 A NO 963143A NO 963143 L NO963143 L NO 963143L
Authority
NO
Norway
Prior art keywords
pct
active substances
colestipol
carries
preparation
Prior art date
Application number
NO963143A
Other languages
English (en)
Other versions
NO963143D0 (no
Inventor
Walter Muller
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO963143D0 publication Critical patent/NO963143D0/no
Publication of NO963143L publication Critical patent/NO963143L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Abstract

Oral legemiddelform med en bærer for surt virkestoff, hvorunder virkestoffet har minst en fri karboksylgruppe som er ionisk bundet til en polymer med tertiasre aminogrupper, er karakterisert ved at polymeren er colestipol hhv. colestipol- hydroklorid.
NO963143A 1994-01-27 1996-07-26 Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne NO963143L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung
PCT/EP1994/004082 WO1995020394A1 (de) 1994-01-27 1994-12-08 Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO963143D0 NO963143D0 (no) 1996-07-26
NO963143L true NO963143L (no) 1996-09-24

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963143A NO963143L (no) 1994-01-27 1996-07-26 Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne

Country Status (22)

Country Link
US (1) US5858344A (no)
EP (1) EP0741574B1 (no)
JP (1) JP3701971B2 (no)
KR (1) KR100439311B1 (no)
AT (1) ATE218371T1 (no)
AU (1) AU697353B2 (no)
CA (1) CA2182417C (no)
CZ (1) CZ291006B6 (no)
DE (2) DE4402379C2 (no)
DK (1) DK0741574T3 (no)
ES (1) ES2177622T3 (no)
FI (1) FI116880B (no)
HU (1) HU223317B1 (no)
IL (1) IL112435A (no)
MY (1) MY113340A (no)
NO (1) NO963143L (no)
NZ (1) NZ277777A (no)
PL (1) PL315619A1 (no)
PT (1) PT741574E (no)
SK (1) SK97296A3 (no)
WO (1) WO1995020394A1 (no)
ZA (1) ZA95638B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
CA2938564C (en) 2006-11-07 2017-04-11 The Procter & Gamble Company Fiber containing compositions and methods of making and using same
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
WO2022259848A1 (ja) 2021-06-07 2022-12-15 国立大学法人筑波大学 高分子化バルプロ酸及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
DE4402379A1 (de) 1995-08-03
JP3701971B2 (ja) 2005-10-05
AU1312795A (en) 1995-08-15
DE59410133D1 (de) 2002-07-11
FI962985A (fi) 1996-07-26
CA2182417A1 (en) 1995-08-03
HU9602041D0 (en) 1996-09-30
HU223317B1 (hu) 2004-05-28
PT741574E (pt) 2002-11-29
DK0741574T3 (da) 2002-09-23
FI962985A0 (fi) 1996-07-26
CZ291006B6 (cs) 2002-11-13
ZA95638B (en) 1995-10-25
PL315619A1 (en) 1996-11-25
CZ221396A3 (en) 1997-01-15
IL112435A (en) 1999-01-26
WO1995020394A1 (de) 1995-08-03
AU697353B2 (en) 1998-10-01
KR970700505A (ko) 1997-02-12
JPH09511488A (ja) 1997-11-18
ATE218371T1 (de) 2002-06-15
EP0741574A1 (de) 1996-11-13
IL112435A0 (en) 1995-03-30
NZ277777A (en) 1997-01-29
US5858344A (en) 1999-01-12
DE4402379C2 (de) 1997-09-25
ES2177622T3 (es) 2002-12-16
MY113340A (en) 2002-01-31
FI116880B (fi) 2006-03-31
NO963143D0 (no) 1996-07-26
SK97296A3 (en) 1997-04-09
KR100439311B1 (ko) 2005-08-17
CA2182417C (en) 2007-04-17
HUT74434A (en) 1996-12-30
EP0741574B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
HU9600572D0 (en) Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form
DK0706378T3 (da) Ny farmaceutisk formulering.
AR003415A1 (es) Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma.
ES2133785T3 (es) Inhibidores de metaloproteinasas.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
DE59609508D1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
NO963143D0 (no) Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
AU9080398A (en) Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
JO1881B1 (en) Formula II for multi unit disc calibration
DE59403326D1 (de) Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE423151T1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.